SMS Pharmaceuticals intimates BSE/NSE of its investor conference call scheduled for May 27, 2026, at 11:00 am IST.
The call will discuss the company's Q4 and full-year FY26 financial results announced on May 22, 2026.
Senior management will participate, and dial-in numbers are provided for global investor access.
The disclosure is a regulatory filing under SEBI LODR Regulation 30, confirming standard compliance.